1
Clinical Trials associated with Autologous HSCs therapy(Acrotech Biopharma)A Phase IIb, Multicenter, Open-Label, Safety and Efficacy Study of High Dose Melphalan HCL for Injection (Propylene Glycol-Free)for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation
The purpose of this trial is to confirm the safety and efficacy of high-dose Melphalan HCL for Injection (Propylene Glycol-Free) as a myeloablative conditioning regimen in multiple myeloma patients (MM) undergoing autologous transplantation.
100 Clinical Results associated with Autologous HSCs therapy(Acrotech Biopharma)
100 Translational Medicine associated with Autologous HSCs therapy(Acrotech Biopharma)
100 Patents (Medical) associated with Autologous HSCs therapy(Acrotech Biopharma)
100 Deals associated with Autologous HSCs therapy(Acrotech Biopharma)